Subtype distribution of lymphomas in South of Iran, analysis of 1085 cases based on World Health Organization classification

详细信息    查看全文

• 作者：Ahmad Monabati ; Akbar Safaei ; Sadat Noori ; Maral Mokhtari…
• 关键词：Lymphoma ; Subtype distribution ; World Health Organization classification ; Iran
• 刊名：Annals of Hematology
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：95
• 期：4
• 页码：613-618
• 全文大小：253 KB
• 参考文献：1.Hanif M, Zaidi P, Kamal S, Hameed A (2009) Institution-based cancer incidence in a local population in Pakistan: nine year data analysis. Asian Pac J Cancer Prev 10:227–30PubMed
  2.Parkin DM, Whelan S, Ferlay J, Storm H (2005) Cancer incidence in five continents. Cancer Base, Lyon
  3.Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (eds) (2007) Cancer Incidence in Five Continents. Lyon, IARC Scientific Publications
  4.Hashemi-Bahremani M, Parwaresch MR, Tabrizchi H et al (2007) Lymphomas in Iran. Arch Iran Med 10:343–8PubMed
  5.Mohagheghi MA, Mosavi-Jarrahi A, Malekzadeh R, Parkin M (2009) Cancer incidence in Tehran metropolis: the first report from the Tehran Population-Based Cancer Registry, 1998–2001. Arch Iran Med 12:15–23PubMed
  6.Swerdlow SH, Campo E, Harris NL, et al. (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. International Agency for Research on Cancer, Lyon
  7.Binesh F, Akhavan A, Behniafard N, Atefi A (2014) Clinicopathologic and survival characteristics of childhood and adolescent non Hodgkin’s lymphoma in Yazd, Iran. Asian Pac J Cancer Prev 15:1585–8CrossRef PubMed
  8.Mozaheb Z, Aledavood A, ONE AUTHOR et al (2011) Distributions of major sub-types of lymphoid malignancies among adults in Mashhad, Iran. Cancer Epidemiol 35:26–9CrossRef PubMed
  9.Morton LM, Wang SS, Devesa SS et al (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood 107:265–76CrossRef PubMed PubMedCentral
  10.Lowry L, Linch D (2013) Non-Hodgkin’s lymphoma. Medicine 41:282–9CrossRef
  11.Troussard X, Duchenet V, Cornet E et al (2009) Haematological malignancies: incidence in Basse-Normandie, France, for 1997–2004. Rev Epidemiol Sante Publique 57:151–8 (in French) CrossRef PubMed
  12.Kilciksiz S, Pehlivan M, Yilmaz EB et al (2011) The clinical and pathological features of patients with hematological neoplasms: a study of hospital-based Cancer Registry from western Turkey. J BUON 16:505–10PubMed
  13.Akhtar SS, Haque IU, Wafa SM et al (2009) Malignant lymphoma in Al-Qassim, Saudi Arabia, reclassified according to the WHO classification. Saudi Med J 30:677–81PubMed
  14.Otrock ZK, Saab J, Aftimos G et al (2013) A collaborative nationwide lymphoma study in Lebanon: incidence of various subtypes and analysis of associations with viruses. Pathol Oncol Res 19:715–22CrossRef PubMed
  15.Sader-Ghorra C, Rassy M, Naderi S, Kourie HR, Kattan J (2014) Type distribution of lymphomas in Lebanon: five-year single institution experience. Asian Pac J Cancer Prev 15:5825–8CrossRef PubMed
  16.Aoki R, Karube K, Sugita Y et al (2008) Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001–2006. Pathol Int 58:174–82CrossRef PubMed
  17.Sukpanichnant S (2004) Analysis of 1983 cases of malignant lymphoma in Thailand according to the World Health Organization classification. Hum Pathol 35:224–30CrossRef PubMed
  18.Chen WL, Tsai WC, Chao TY et al (2010) The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan. Ann Hematol 89:553–62CrossRef PubMed
  19.Yang QP, Zhang WY, Yu JB et al (2011) Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol 6:77CrossRef PubMed PubMedCentral
  20.Sun J, Yang QP, Lu Z et al (2012) Distribution of lymphoid neoplasms in China. Analysis of 4,638 cases according to the World Health Organization classification. Am J Clin Pathol 138:429–34CrossRef PubMed
  21.International Lymphoma Study Group (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. The Non-Hodgkin’s Lymphoma Classification Project. Blood 89:3909–18
  22.Biagi JJ, Seymour JF (2002) Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood 99:4265–75CrossRef PubMed
  23.Zucca E, Roggero E, Bertoni F, Conconi A, Cavalli F (1999) Primary extranodal non-Hodgkin’s lymphomas. Part 2: Head and neck, central nervous system and other less common sites. Ann Oncol 10:1023–33CrossRef PubMed
  24.Cavalli F, Stein H, Zucca E (2008) Extranodal lymphomas: pathology and management. Informa Healthcare, LondonCrossRef
  25.Krol ADG, le Cessie S, Snijder S et al (2003) Primary extranodal non-Hodgkin’s lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol 14:131–9CrossRef PubMed
  26.Yoon SO, Suh C, Lee DH et al (2010) Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification. Am J Hematol 85:760–4CrossRef PubMed
  
• 作者单位：Ahmad Monabati (1)
  Akbar Safaei (2)
  Sadat Noori (2)
  Maral Mokhtari (2)
  Amir Vahedi (3)
  
  1. Department of Pathology and Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  2. Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran
  3. Department of Pathology, Tabriz University of Medical Sciences, Tabriz, Iran
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Hematology
  Oncology
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1432-0584

文摘

Lymphoma is one of the most common malignancies worldwide. Subtype distribution is different throughout the world. Some reports from the Middle East are in record. This article is trying to report the subtype distribution of lymphoma in Iran and compare it to that of Western, Far East Asian and Middle Eastern countries. A retrospective study was done on all lymphomas diagnosed in a large referral center in the South of Iran during a time period between 2009 and 2014. All diagnoses have been made according to 2008 WHO classification. A total number of 1085 cases with diagnoses of lymphoma retrieved. Twenty-nine cases (2.6 % of all) were precursor lymphoid neoplasm, 608 cases (56 % of all) were mature B cell neoplasm, 115 cases (10.5 % of all) were mature T and NK cell neoplasm, and 333 cases (30.6 % of all) were Hodgkin lymphoma. The six most frequent subtypes of mature B cell neoplasm were diffuse large B cell lymphoma, NOS (57 %), Burkitt lymphoma (7 %), small lymphocytic lymphoma (6.9 %), mantle cell lymphoma (5.7 %), extranodal marginal zone B cell lymphoma (5.2 %) and follicular lymphoma (3.6 %). Among mature T and NK cell neoplasm, mycosis fungoides was the most common type (43.4 %) followed by peripheral T cell lymphoma, NOS (20 %) and angioimmunoblastic T cell lymphoma (9.9 %). Of Hodgkin lymphoma cases, 90.6 % were classical type and 9.3 % were nodular lymphocyte predominant Hodgkin lymphoma. Extranodal involvement was seen in 42.2 % and GI tract was the most common site. Lymphoma frequencies were similar to that of Middle Eastern countries except for lower rate of follicular lymphoma and higher incidence of diffuse large B cell lymphoma, NOS and small lymphocytic lymphoma.